IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses - PubMed (original) (raw)
IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses
Michelle A Linterman et al. J Exp Med. 2010.
Abstract
During T cell-dependent responses, B cells can either differentiate extrafollicularly into short-lived plasma cells or enter follicles to form germinal centers (GCs). Interactions with T follicular helper (Tfh) cells are required for GC formation and for selection of somatically mutated GC B cells. Interleukin (IL)-21 has been reported to play a role in Tfh cell formation and in B cell growth, survival, and isotype switching. To date, it is unclear whether the effect of IL-21 on GC formation is predominantly a consequence of this cytokine acting directly on the Tfh cells or if IL-21 directly influences GC B cells. We show that IL-21 acts in a B cell-intrinsic fashion to control GC B cell formation. Mixed bone marrow chimeras identified a significant B cell-autonomous effect of IL-21 receptor (R) signaling throughout all stages of the GC response. IL-21 deficiency profoundly impaired affinity maturation and reduced the proportion of IgG1(+) GC B cells but did not affect formation of early memory B cells. IL-21R was required on GC B cells for maximal expression of Bcl-6. In contrast to the requirement for IL-21 in the follicular response to sheep red blood cells, a purely extrafollicular antibody response to Salmonella dominated by IgG2a was intact in the absence of IL-21.
Figures
Figure 1.
IL-21–deficient mice form detectable GCs after immunization, but the kinetics of the GC is altered. (A and B) ELISA analysis of total serum IgG1 (A) and IgE (B) in unimmunized mice of the indicated genotypes. (C) Flow cytometric contour plots and graphical analysis of GL-7+Fas+ GC cells gated on live B220+ lymphocytes from Il21+/+ and Il21−/− mice at the indicated time points after SRBC immunization. Each symbol represents one mouse. (D) Photomicrographs of spleen sections stained for IgD (brown) and PNA (blue) from Il21+/+ and Il21−/− mice 8 d after immunization. Data are representative of two independent experiments (n ≥ 4 per group). Bars, 200 µm. (E) Flow cytometric histograms and graphical analysis of PNA binding on GL-7+Fas+B220+ GC B cells from Il21+/+ and Il21−/− mice 7 d after SRBC immunization. Statistically significant differences are indicated (*, P ≤ 0.05; **, P ≤ 0.01). Data are representative of two independent experiments, each symbol represents one mouse, and tops of bars are drawn through the median values. MFI, mean fluorescence intensity; ns, not significant.
Figure 2.
IL-21–deficient mice form Tfh cells after immunization, but their maintenance is impaired. (A) Flow cytometric contour plots and graphical analysis of CXCR5+PD-1+ Tfh cells gated on CD4+ B220− live lymphocytes from Il21+/+ and Il21−/− mice at the indicated time points after SRBC immunization (percentages are shown). (B) Photomicrographs of spleen sections taken from Il21+/+ (top) and Il21−/− (bottom) mice 8 d after immunization with SRBCs. In all panels, IgD is stained in brown; blue color stains indicate PNA binding (left), CD3 (middle), and PD-1 (right). Bars, 200 µm. Statistically significant differences are indicated (*, P ≤ 0.05). Data are representative of two independent experiments, each symbol represents one mouse, and tops of bars are drawn through the median values. ns, not significant.
Figure 3.
IL-21R expression is required on both GC B cells and Tfh cells for their maintenance but is dispensable for their formation. (A and B) Gating strategy (A) and bar graphs (B) of mixed bone marrow chimeras containing a 1:1 ratio of control _Il21r+/+_CD45.1/_Il21r+/+_CD45.2 or _Il21r+/+_CD45.1/_Il21r−/−_CD45.2 bone marrow. Spleens from unimmunized mice (A; and B, top) or from mice immunized with SRBCs 6 or 14 d previously (B, middle and bottom) were analyzed by flow cytometry for the percentage of B220+ B cells that are CD45.2+ (B220+), the percentage of GL-7+Fas+ GC cells among B220+ cells that are CD45.2+ (GC cells), the percentage of CD4+ Th cells that are CD45.2+ (CD4+), and the percentage of CXCR5highPD-1high Tfh cells among CD4+ cells that are CD45.2+ (Tfh cells). Each bar represents a single recipient mouse; individual mice have been numbered and placed in the same order in each of the plots. Statistically significant decreases are indicated (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001). Data are representative of two independent experiments. (C and D) Gating strategy (C) and dot plots (D) of the proportion of B220+, GC (B220+Fas+GL-7+), and IgG1+ GC (B220+Fas+GL-7+IgG1+) cells derived from the CD45.2 compartment of mixed chimeras reconstituted with a 1:1 ratio of either CD45.1 Il21r+/+/CD45.2 Il21r+/+ (left) or CD45.1 Il21r+/+/CD45.2 Il21r−/− (right) bone marrow before (C; and D, top) or 6 d after SRBC immunization (D, bottom). In D, each number represents a single recipient mouse from two separate groups of the chimeric mice indicated above the left and right panels.
Figure 4.
IL-21 contributes to affinity maturation but is dispensable for EM B cell formation. (A) Representative flow cytometric contour plots of donor CD45.1 SWHEL cells from the spleens of Il21+/+ or Il21−/− recipient mice 10 d after adoptive transfer and immunization with HEL3X SRBCs. Contour plots show IgG1+ cells binding with high (top oval gates) and low (bottom oval gates) affinity to HEL3X (percentages are shown). (B) Bar graphs show HEL3X hi IgG1+ CD45.1 cells (top oval gates in A) as a proportion of all HEL3X-binding IgG1+ cells (square gates in A). This figure is representative of two independent experiments (n ≥ 3 mice per group. (C) Ratio of total Tfh (CXCR5highPD-1high CD4+) cells to total HEL-binding donor (CD45.1) GC B cells (Fas+GL-7+). Two independent experiments are represented in this plot. (D) Representative flow cytometric contour plots 10 d after adoptive transfer of SWHEL B cells into Il21+/+ or Il21−/− mice and immunization with HEL3X SRBCs gated on donor CD45.1 and HEL-binding cells (percentages are shown). The gates show GC cells (HELint binding) and EM B cells (HELhi binding). (E) Phenotype of GC B cells and EM cells gated as in D. (F and G) Total number of donor HELint-binding GC B cells per spleen (F) and the proportion of donor HELhi-binding EM B cells (G) in mice of the indicated genotypes gated as in D. Each symbol represents one mouse and tops of bars are drawn through the median values. Statistically significant differences are indicated (**, P ≤ 0.01).
Figure 5.
Lack of IL-21R signaling reduces the expression of Bcl-6 in GC B cells. (A) Flow cytometric contour plots indicating the gating strategy for non-GC and GC B220+ cells (left) and BCL-6 expression on GL-7+ (middle) and Fas+ (right) B cells. (B and C) Histogram overlays (B) and bar graphs (C) showing the fluorescence intensity of BCL-6 staining in GC and non-GC B cells as gated in A derived from the CD45.1 Il21r+/+ or CD45.2 Il21−/− compartment of CD45.1 Il21r+/+/CD45.2 Il21r−/− mixed bone marrow chimeras 6 d after SRBC immunization. The horizontal dashed line highlights the median levels of Bcl-6 found in non-GC B cells. Each set of two bars represents the data from the CD45.1 and CD45.2 compartments of a single mouse. MFI, mean fluorescence intensity.
Figure 6.
Lack of IL-21 does not alter Salmonella pathogen clearance or production of anti-Salmonella humoral immunity. (A) ELISA analysis of the titers of _Salmonella_-specific IgM, IgG1, IgG2ab, IgG2b, and IgG3 in sera from Il21+/+(white bars) and Il21−/− (black bars) mice 12 d after Salmonella infection. (B and C) Dot plots of spleen weights (B) and the number of bacteria per liver (C) in Il21+/+ and Il21−/− mice 12 d after infection with Salmonella. Data are representative of two independent experiments. Each symbol represents one mouse and tops of bars are drawn through the median values. nd, not detected.
Similar articles
- IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism.
Zotos D, Coquet JM, Zhang Y, Light A, D'Costa K, Kallies A, Corcoran LM, Godfrey DI, Toellner KM, Smyth MJ, Nutt SL, Tarlinton DM. Zotos D, et al. J Exp Med. 2010 Feb 15;207(2):365-78. doi: 10.1084/jem.20091777. Epub 2010 Feb 8. J Exp Med. 2010. PMID: 20142430 Free PMC article. - B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells.
Lee SK, Rigby RJ, Zotos D, Tsai LM, Kawamoto S, Marshall JL, Ramiscal RR, Chan TD, Gatto D, Brink R, Yu D, Fagarasan S, Tarlinton DM, Cunningham AF, Vinuesa CG. Lee SK, et al. J Exp Med. 2011 Jul 4;208(7):1377-88. doi: 10.1084/jem.20102065. Epub 2011 Jun 27. J Exp Med. 2011. PMID: 21708925 Free PMC article. - Orphan Nuclear Receptor NR2F6 Suppresses T Follicular Helper Cell Accumulation through Regulation of IL-21.
Olson WJ, Jakic B, Labi V, Schoeler K, Kind M, Klepsch V, Baier G, Hermann-Kleiter N. Olson WJ, et al. Cell Rep. 2019 Sep 10;28(11):2878-2891.e5. doi: 10.1016/j.celrep.2019.08.024. Cell Rep. 2019. PMID: 31509749 Free PMC article. - Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses.
Pedros C, Altman A, Kong KF. Pedros C, et al. Front Immunol. 2018 Oct 22;9:2412. doi: 10.3389/fimmu.2018.02412. eCollection 2018. Front Immunol. 2018. PMID: 30405612 Free PMC article. Review. - T follicular helper (Tfh ) cells in normal immune responses and in allergic disorders.
Varricchi G, Harker J, Borriello F, Marone G, Durham SR, Shamji MH. Varricchi G, et al. Allergy. 2016 Aug;71(8):1086-94. doi: 10.1111/all.12878. Epub 2016 May 25. Allergy. 2016. PMID: 26970097 Review.
Cited by
- Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.
Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z, Wang X, Huang S, Zhang D, Wu H. Zhao L, et al. Signal Transduct Target Ther. 2024 Aug 28;9(1):225. doi: 10.1038/s41392-024-01947-5. Signal Transduct Target Ther. 2024. PMID: 39198425 Free PMC article. Review. - Role of TGFβ-producing regulatory T cells in scleroderma and end-stage organ failure.
Lu KC, Tsai KW, Hu WC. Lu KC, et al. Heliyon. 2024 Aug 2;10(15):e35590. doi: 10.1016/j.heliyon.2024.e35590. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170360 Free PMC article. Review. - Immune and inflammation features of severe and critical Omicron infected patients during Omicron wave in China.
Liu Y, Guo Y, Zhan H, Liu X, Li X, Cui J, Li H, Feng S, Cheng L, Li X, Guo S, Li Y. Liu Y, et al. BMC Infect Dis. 2024 Aug 9;24(1):809. doi: 10.1186/s12879-024-09652-y. BMC Infect Dis. 2024. PMID: 39123106 Free PMC article. - Modulation of T-Cell-Dependent Humoral Immune Response to Influenza Vaccine by Multiple Antioxidant/Immunomodulatory Micronutrient Supplementation.
Bufan B, Arsenović-Ranin N, Živković I, Ćuruvija I, Blagojević V, Dragačević L, Kovačević A, Kotur-Stevuljević J, Leposavić G. Bufan B, et al. Vaccines (Basel). 2024 Jul 4;12(7):743. doi: 10.3390/vaccines12070743. Vaccines (Basel). 2024. PMID: 39066381 Free PMC article. - Transcriptional regulation of Tfh dynamics and the formation of immunological synapses.
Kim YJ, Choi J, Choi YS. Kim YJ, et al. Exp Mol Med. 2024 Jun;56(6):1365-1372. doi: 10.1038/s12276-024-01254-7. Epub 2024 Jun 3. Exp Mol Med. 2024. PMID: 38825646 Free PMC article. Review.
References
- Avery D.T., Bryant V.L., Ma C.S., de Waal Malefyt R., Tangye S.G. 2008. IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4. J. Immunol. 181:1767–1779 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous